J&J beats on earnings but warns of potential job cuts

  • 📰 RTEbusiness
  • ⏱ Reading Time:
  • 27 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 61%

Indonesia Berita Berita

Indonesia Berita Terbaru,Indonesia Berita utama

Johnson & Johnson has posted better than expected third-quarter earnings on strong demand for its cancer drug Darzalex, but said it may still cut some jobs as it contends with inflationary pressure and challenges created by the strong dollar.

J&J Chief Financial Officer Joseph Wolk said the U.S. healthcare conglomerate is looking at"right sizing" itself, particularly as it moves from being a three-segment business to a two segment business through the spinoff of its consumer unit.

J&J said it was not immune to the affects of inflation on its business and the impact of a strong dollar, despite"healthcare being more resilient" than most industries. "We are looking at making sure that our resources are deployed on those projects, those initiatives, those services that really add the most value for our business," Wolk told Reuters.

The share move was mainly due to macroeconomic and currency concerns which are not unique to J&J, said Edward Jones analyst John Boylan.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

 /  🏆 16. in İD
 

Terima kasih atas komentar Anda. Komentar Anda akan dipublikasikan setelah ditinjau.

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

European stocks are cheap, but risks remainPrice/earnings ratios will look less attractive when earnings inevitably fall
Sumber: IrishTimes - 🏆 3. / 98 Baca lebih lajut »